Locally Advanced Breast Cancer Clinical Trials in Beijing
3 recruitingBeijing, China
Showing 1–3 of 3 trials
Recruiting
A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer
Metastatic Breast CancerLocally Advanced Breast Cancer
Hoffmann-La Roche500 enrolled23 locationsNCT07347600
Recruiting
Phase 2
Evaluate the Efficacy and Safety of Adebrelimab Combined With Chemotherapy With or Without Radiotherapy as Neoadjuvant Treatment for HER2-Negative Locally Advanced Breast Cancer
HER2-Negative Locally Advanced Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences170 enrolled1 locationNCT06908668
Recruiting
Not Applicable
The Choice of Treatment Methods and Efficacy of LABC
Locally Advanced Breast Cancer
Peking Union Medical College Hospital50 enrolled1 locationNCT06080620